iScience (Apr 2018)

ALPK2 Promotes Cardiogenesis in Zebrafish and Human Pluripotent Stem Cells

  • Peter Hofsteen,
  • Aaron Mark Robitaille,
  • Nicholas Strash,
  • Nathan Palpant,
  • Randall T. Moon,
  • Lil Pabon,
  • Charles E. Murry

Journal volume & issue
Vol. 2
pp. 88 – 100

Abstract

Read online

Summary: Cardiac development requires coordinated biphasic regulation of the WNT/β-catenin signaling pathway. By intersecting gene expression and loss-of-function siRNA screens we identified Alpha Protein Kinase 2 (ALPK2) as a candidate negative regulator of WNT/β-catenin signaling in cardiogenesis. In differentiating human embryonic stem cells (hESCs), ALPK2 is highly induced as hESCs transition from mesoderm to cardiac progenitors. Using antisense knockdown and CRISPR/Cas9 mutagenesis in hESCs and zebrafish, we demonstrate that ALPK2 promotes cardiac function and cardiomyocyte differentiation. Quantitative phosphoproteomics, protein expression profiling, and β-catenin reporter assays demonstrate that loss of ALPK2 led to stabilization of β-catenin and increased WNT signaling. Furthermore, cardiac defects attributed to ALPK2 depletion can be rescued in a dose-dependent manner by direct inhibition of WNT signaling through the small molecule XAV939. Together, these results demonstrate that ALPK2 regulates β-catenin-dependent signaling during developmental commitment of cardiomyocytes. : Piscine Cardiology; Stem Cell Research; Developmental Biology Subject Areas: Piscine Cardiology, Stem Cell Research, Developmental Biology